Hospital.Help

Leiden/Netherlands – A new live vaccine against Plasmodium falciparum, the pathogen that causes malaria tropica, protected eight out of nine test subjects from later infection in an initial “proof of principle” study. The results published in the New England Journal of Medicine (2024; DOI: 10.1056/NEJMoa2313892) could lead to the development of a more effective vaccine. The two currently available vaccines RTS,S/AS01 (Mosquirix) and…